James Cancer Hospital Launches Online Cancer Community
COLUMBUS, Ohio – Cancer patients seeking to connect with others facing similar challenges are invited to join a new social media network called CancerConnect that will allow them and their caregivers
CEO of The James to Discuss Future of Cancer Research, Prevention, Treatment
COLUMBUS, Ohio –Dr. Michael Caligiuri, director of The Ohio State University Comprehensive Cancer Center and CEO of the Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC
Internationally Renowned Gynecologic Cancer Researcher Joins Ohio State
COLUMBUS, Ohio – Internationally renowned uterine cancer researcher and geneticist Paul Goodfellow will lead a new team of three researchers devoted to gynecologic oncology research at The Ohio State
Older And Younger Chronic Leukemia Patients May Need Different Therapy
People who develop chronic lymphocytic leukemia (CLL) are typically age 65 and older, but participants in CLL clinical trials are usually several years younger;
The age of CLL patients is not usually
Reduced Intensity Regimen Prior to Bone Marrow Transplant Better for Older Leukemia Patients
COLUMBUS, Ohio – A new study led by researchers at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) sho
Updated Clinical Results Show Experimental Agent Ibrutinib as Highly Active in CLL Patients
COLUMBUS, Ohio – Updated results from a Phase Ib/II clinical trial indicates that a novel therapeutic agent for chronic lymphocytic leukemia (CLL) is highly active and well tolerated in patients who h
The James Earns Top Hospital Status for Fifth Time in Six Years
COLUMBUS, Ohio – For the fourth consecutive year – and the fifth time in six years – the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Rese
Low-dose CT Scans Offer Earlier Detection of Lung Cancer
COLUMBUS, Ohio – The best way to catch lung cancer early is through early
detection, says Dr.
David Carbone, director of the new thoracic oncology center at The Ohio
State University Comprehensi
Patient’s Own Immune Cells May Blunt Viral Therapy For Brain Cancer
People with a type of brain tumor called glioblastoma live 12 months on average, so new forms of treatment are badly needed for this malignancy.
Viruses designed to kill cancer cells offer a safe way
Delayed Treatment for Advanced Breast Cancer Has 'Profound Effect
COLUMBUS, Ohio – Results from a new study conducted by researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (
Early Childhood Neglect May Raise Risk of Adult Skin Cancer
COLUMBUS, Ohio - Skin cancer patients whose childhood included periods of neglect or maltreatment are at a much greater risk for their cancers to return when they face a major stressful event, based o
Study Shows How Chronic Inflammation Can Cause Cancer
Chronic inflammation like sunburn can sometimes cause cancer, but how it happens remains unknown.
This study shows for the first time how a substance made by the body to promote inflammation can caus
Crops to Clinic: Researchers Create, Test Cancer-fighting Foods
COLUMBUS, Ohio – At a time of year when many American families gather to pile food on holiday plates, cancer researchers urge families to save more space for colorful fruits and vegetables that may he
Cancer Genomics Expert To Present Annual Block Lecture
COLUMBUS, Ohio – Dr. Levi Garraway, an
associate professor of medicine in the Department of Medical Oncology at the
Dana-Farber Cancer Institute, Harvard
and a senior associat
Guides Help Cancer Patients Navigate Health System, Complete Therapy
COLUMBUS, Ohio – They’re called patient navigators, but some might call them hurdle jumpers, task masters, or simply strong shoulders to lean on. People who first learn they might have cancer often n
Internationally Renowned Lung Cancer Expert Comes To Ohio State
COLUMBUS, Ohio – Internationally renowned lung cancer expert Dr. David Carbone will be developing and leading a new thoracic oncology center at The Ohio State University Comprehensive Cancer Center
New Pelotonia 'Idea Grants' in Cancer Research Awarded at Ohio State
NEW PELOTONIA ‘IDEA GRANTS’ IN CANCER RESEARCH AWARDED AT OHIO STATE
COLUMBUS, Ohio – The Ohio State University’s Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J.
Join the Conversation about Breast Reconstruction
COLUMBUS, Ohio – The Stefanie Spielman Comprehensive Breast Center is hosting a live, interactive webinar from noon to 1 p.m. Wednesday (10/17) with breast reconstructive surgery experts and patients
Nurses, Volunteers At The James Create 'Dream Hats' For Patients
COLUMBUS, Ohio – Oncology
nurses and volunteers at the Ohio State University Comprehensive Cancer Center
– Arthur G. James Cancer Hospital
and Richard J. Solove Research Institute (OSUCCC–James) a
Seeking Nominations for Stefanie's Champions Caregivers
COLUMBUS, Ohio – The 14th annual Stefanie’s Champions Awards is seeking nominations for caregivers who are helping improve the lives of cancer patients. Five Champions will be honored during the annu
The James Turns Columbus Pink For Breast Cancer Awareness
COLUMBUS, Ohio – In honor of Breast Cancer Awareness month, the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC–Ja
Media Advisory: The James To Celebrate 'Cancer Survivors Day' on Sunday
– Thousands of cancer survivors and their families will be swaying to the
music, and listening to inspirational speakers when they gather on the lawn of
Chemical Abstracts Services,
Robotic Surgery Through The Mouth Safe For Removing Tumors Of The Voice Box, Study Shows
COLUMBUS, Ohio – Robotic surgery though the mouth is a safe and effective way to remove tumors of the throat and voice box, according to a study by head and neck cancer surgeons at the Ohio State Uni
Ohio State And Malaysia Centre Join Forces In The Global Fight Against Cancer, Develop Possible Anticancer Drug
Tropical plants can be a valuable source of new anticancer drugs.
A formal collaboration with the Sarawak Biodiversity Centre, a Malaysian research organization, has been initiated to study a new exp
Breast Cancer Conference to Feature Experts from The James
COLUMBUS, Ohio – Community members are invited to attend a breast cancer conference with Dr. Charles L. Shapiro, professor of medical oncology and director of breast medical oncology at The Ohio Sta
Media Advisory: OSU James Offering Free Prostate Cancer Screenings
COLUMBUS, Ohio – The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC–James) is offering free prostate cancer scree
Possible Therapy For Tamoxifen-Resistant Breast Cancer Identified
Sarmila Majumder, PhD
The hormone estrogen stimulates the growth of breast cancers that are estrogen-receptor positive, the most common form of breast cancer.
The drug tamoxifen blocks this estro
Ohio State Leads International Pancreatic Cancer Treatment Development Effort
COLUMBUS, Ohio – An estimated 44,000 Americans will be diagnosed with pancreatic cancer this year – and an estimated 37,000 will die from the disease – making it the fourth leading cancer killer, acc
National Food Magazine Awards 'Top Doc' Competition 'Best Special Event
COLUMBUS, Ohio – The first-ever “Top Doc” Cooking Challenge – an informational and entertaining food event similar to the popular TV shows “Top Chef” and “Chopped” – has received the Best Special Eve
Dr. Clinton to Discuss Prostate Cancer During 'Fireside Chat
COLUMBUS, Ohio – Community members are invited to attend a “fireside chat” about prostate cancer with Dr. Steven Clinton, program leader of molecular carcinogenesis and chemoprevention at The Ohio St
Combination Peptide Therapies Might Offer More Effective, Less Toxic Cancer Treatment
Tiny fragments of proteins called peptides potentially offer an effective, safer, way to prevent or treat cancer.
These two studies examine a peptide vaccine and a peptide therapeutic together and wi
The James Cancer Hospital Expands Gastrointestinal Oncology Program
COLUMBUS, Ohio – The section of gastrointestinal oncology at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC-James) continues to ex
Electric Helmet Treats Brain Tumors
COLUMBUS, Ohio – Brain cancer patients at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC–James) are among the
People With Allergies May Have Lower Risk of Brain Tumors
COLUMBUS, Ohio - New research adds to the growing body of evidence suggesting that there’s a link between allergies and reduced risk of a serious type of cancer that starts in the brain. This study su
Liver Cancer Cells Stop Making Glucose As They Become Cancerous
Liver cells normally produce glucose to help maintain healthy blood-sugar levels, but they lose that ability when they become cancerous, this study shows.
This change might benefit tumor cells by hel
Loss Of A Tiny Liver Molecule Might Lead To Liver Cancer
Liver cancer is the third leading cancer killer worldwide and new treatments are urgently needed.
This study shows that loss of a regulatory molecule called microRNA-122 leads to liver cancer.
Study Reveals New Mechanism That Might Promote Cancer’s Growth And Spread In The Body
Researchers have discovered a previously unknown mechanism that promotes the growth and spread of cancer.
The mechanism involves a new role for small regulatory molecules called microRNA.
Ohio State Cancer Researcher Receives Carcinogenesis Award
COLUMBUS, Ohio – Dr. Carlo Croce, chair of the department of molecular virology, immunology, and medical genetics; and director of Human Cancer Genetics at The Ohio State University Comprehensive Canc
miR Loss May Power Malignant Transformation In Chronic Leukemia
These findings show that the loss of a particular RNA molecule enables leukemia cells to generate energy in a way that allows them to rapidly produce materials they need to proliferate faster.
Goldberg Gives Moertel Lecture At Alliance Meeting
COLUMBUS, Ohio – Dr. Richard Goldberg, (43235) an internationally renowned gastrointestinal oncologist at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Resea
Paskett Presents Jimmie Holland Lecture at National Alliance Meeting
COLUMBUS, Ohio – Ohio State University cancer researcher Electra Paskett (43017) presented the 12th annual Jimmie Holland lecture during the recent Alliance for Clinical Trials in Oncology meeting in
Ohio State Leukemia Researcher Receives National Schilsky Award
COLUMBUS, OHIO – Dr. Clara Bloomfield (43015), an international authority on leukemia and lymphoma at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research
International Expert In Breast Radiation Oncology Joins The James
COLUMBUS, Ohio – Internationally renowned cancer expert Dr. Julia White is the new director of breast radiation oncology at The Ohio State University Comprehensive Cancer Center – Arthur G. James Can
Inhibitors Of Shuttle Molecule Show Promise In Acute Leukemia
An estimated 10,200 Americans will die of acute myeloid leukemia (AML) in 2012, so new ways of treating the disease are needed.
This study uses a novel class of experimental drugs to halt a process
Scientists Sequence Genome Of Human Relative That Prefers Love Over War
Researchers have sequenced the bonobo genome and compared it to the genomes of chimpanzees and humans.
The findings should help scientists better understand the evolutionary relationships between
Marker Distinguishes More-Aggressive From Less-Aggressive Forms Of Chronic Leukemia
People newly diagnosed with chronic leukemia must often wait to learn if they have a faster- or slower-progressing form of the disease.
This study identified a molecular marker that quickly helps to
Researchers Identify a “Life-And-Death” Molecule on Chronic Leukemia Cells
SMIP-016 is a promising experimental drug that kills chronic leukemia cells.
The drug targets a protein called CD37, but it wasn’t known how this kills leukemia cells.
This study showed unexpected
Inherited DNA Change Explains Overactive Leukemia Gene
An overactive BAALC gene in acute leukemia cells identifies patients whose disease is likely to respond poorly to standard therapy.
This study discovered why the gene is often overactive.
Revised Glioblastoma Classification Should Improve Patient Care
Classification Should Improve Patient Care
The system doctors use to classify patients’ malignant brain
tumors is outdated.
Researchers have revised the
Experimental Agent May Help Older People With Chronic Leukemia
· Standard treatment for chronic leukemia is too harsh for many older patients.
· Early clinical trials testing indicates that these patients respond well to the experimental drug